Cargando…

A review of the Bayesian approach with the MCMC and the HMC as a competitor of classical likelihood statistics for pharmacometricians

This article reviews the Bayesian inference with the Monte Carlo Markov Chain (MCMC) and the Hamiltonian Monte Carlo (HMC) samplers as a competitor of the classical likelihood statistical inference for pharmacometricians. The MCMC and the HMC samplers have greatly contributed to realization of the B...

Descripción completa

Detalles Bibliográficos
Autor principal: Choi, Kyungmee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society for Clinical Pharmacology and Therapeutics 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10333649/
https://www.ncbi.nlm.nih.gov/pubmed/37440780
http://dx.doi.org/10.12793/tcp.2023.31.e9
_version_ 1785070708668235776
author Choi, Kyungmee
author_facet Choi, Kyungmee
author_sort Choi, Kyungmee
collection PubMed
description This article reviews the Bayesian inference with the Monte Carlo Markov Chain (MCMC) and the Hamiltonian Monte Carlo (HMC) samplers as a competitor of the classical likelihood statistical inference for pharmacometricians. The MCMC and the HMC samplers have greatly contributed to realization of the Bayesian methods with minimal requirement of mathematical theory. They do not require any closed form of the posterior density nor linear approximation of complex nonlinear models in high dimension even with non-conjugate priors. The HMC even weakens the dependency of the chain and improves computational efficiency. Pharmacometrics is one of great beneficiaries since they use complex multivariate multilevel nonlinear mixed effects models based on the restricted maximum likelihood estimation. Comprehension of the Bayesian approach will help pharmacometricians to access the data analysis more conveniently.
format Online
Article
Text
id pubmed-10333649
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Korean Society for Clinical Pharmacology and Therapeutics
record_format MEDLINE/PubMed
spelling pubmed-103336492023-07-12 A review of the Bayesian approach with the MCMC and the HMC as a competitor of classical likelihood statistics for pharmacometricians Choi, Kyungmee Transl Clin Pharmacol Review Article This article reviews the Bayesian inference with the Monte Carlo Markov Chain (MCMC) and the Hamiltonian Monte Carlo (HMC) samplers as a competitor of the classical likelihood statistical inference for pharmacometricians. The MCMC and the HMC samplers have greatly contributed to realization of the Bayesian methods with minimal requirement of mathematical theory. They do not require any closed form of the posterior density nor linear approximation of complex nonlinear models in high dimension even with non-conjugate priors. The HMC even weakens the dependency of the chain and improves computational efficiency. Pharmacometrics is one of great beneficiaries since they use complex multivariate multilevel nonlinear mixed effects models based on the restricted maximum likelihood estimation. Comprehension of the Bayesian approach will help pharmacometricians to access the data analysis more conveniently. Korean Society for Clinical Pharmacology and Therapeutics 2023-06 2023-06-26 /pmc/articles/PMC10333649/ /pubmed/37440780 http://dx.doi.org/10.12793/tcp.2023.31.e9 Text en Copyright © 2023 Translational and Clinical Pharmacology https://creativecommons.org/licenses/by-nc/4.0/It is identical to the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/).
spellingShingle Review Article
Choi, Kyungmee
A review of the Bayesian approach with the MCMC and the HMC as a competitor of classical likelihood statistics for pharmacometricians
title A review of the Bayesian approach with the MCMC and the HMC as a competitor of classical likelihood statistics for pharmacometricians
title_full A review of the Bayesian approach with the MCMC and the HMC as a competitor of classical likelihood statistics for pharmacometricians
title_fullStr A review of the Bayesian approach with the MCMC and the HMC as a competitor of classical likelihood statistics for pharmacometricians
title_full_unstemmed A review of the Bayesian approach with the MCMC and the HMC as a competitor of classical likelihood statistics for pharmacometricians
title_short A review of the Bayesian approach with the MCMC and the HMC as a competitor of classical likelihood statistics for pharmacometricians
title_sort review of the bayesian approach with the mcmc and the hmc as a competitor of classical likelihood statistics for pharmacometricians
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10333649/
https://www.ncbi.nlm.nih.gov/pubmed/37440780
http://dx.doi.org/10.12793/tcp.2023.31.e9
work_keys_str_mv AT choikyungmee areviewofthebayesianapproachwiththemcmcandthehmcasacompetitorofclassicallikelihoodstatisticsforpharmacometricians
AT choikyungmee reviewofthebayesianapproachwiththemcmcandthehmcasacompetitorofclassicallikelihoodstatisticsforpharmacometricians